Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X antigen family member 1A (XAGE1A) is a member of the GAGE family of cancer-testis (CT) antigens, characterized by expression in various tumors (such as Ewing’s sarcoma, rhabdomyosarcoma, and ovarian carcinoma) and normal testis, but generally not in other normal tissues[1][2][3][5][6]. The protein contains a nuclear localization signal, and alternative splicing produces multiple isoforms. XAGE1A and related CT antigens are involved in normal germ cell biology (spermatogenesis) and may contribute to tumor development and metastatic progression, notably through mechanisms such as apoptosis avoidance and potentially promoting epithelial-to-mesenchymal transition (EMT)[2][4]. High XAGE1A expression serves as a specific biomarker for several cancers—especially ovarian cancer, where it can differentiate malignant from benign lesions and is linked to poor prognosis and advanced stage[2][6]. XAGE1A is being investigated as a candidate for cancer diagnosis and immunotherapy[2][4][6]. No direct information is available for approved drug interactions or specific molecular inhibitors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X antigen family member 1A (XAGE1A).